Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help

337 results

  1. NLM Digital Collections - Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors : effectiveness and .... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, November 25, 2018
    resource.nlm.nih.gov/101745056
    Angioedemas, Hereditary -- prevention & control ... value : final evidence report Angioedemas, Hereditary -- drug therapy Angioedemas, Hereditary -- prevention & control Antibodies, Monoclonal, Humanized -- therapeutic use Complement C1 ...
  2. NLM Digital Collections - Observational real-world evidence update : prophylaxis of hereditary angioedema with Takhzyro ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 24, 2021
    resource.nlm.nih.gov/9918401082906676
    Angioedemas, Hereditary -- prevention & control ... author. Patrick, Amanda, author. Campbell, Jon D., author. Angioedemas, Hereditary -- prevention & control Complement C1 Inhibitor Protein In 2018, The ...
  3. Cost Comparison - Pharmacoeconomic Review Report: Lanadelumab (Takhzyro) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK558383
    ... Drug Review Cost Comparison Table for the Routine Prevention of Hereditary Angioedema Attacks View in own window Drug/Comparator Strength ... Shire Pharma Canada ULC): Indication: For the routine prevention of attacks of hereditary angioedema in adolescents and adults [Internet]. Ottawa (ON): Canadian ...
  4. Berotralstat (Orladeyo) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK596312
    ... in combination with other medications for long-term prevention of angioedema. Orladeyo should only be reimbursed if its cost ... recommends that berotralstat be reimbursed for the routine prevention of attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years ...
  5. Hereditary angioedema 
    https://medlineplus.gov/ency/article/001456.htm
    ... C, Mills K. Interventions for the long-term prevention of hereditary angioedema attacks. Cochrane Database Syst Rev . 2022;11(11): ...
  6. Hereditary Angioedema Agents - LiverTox - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK605174
    ... Baker J, Li HH, Ret al; COMPACT Investigators. Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor. N Engl ... hepatotoxicity). Haegarda--a subcutaneous C1 esterase inhibitor for prevention of hereditary angioedema. Med Lett Drugs Ther. 2018;60(1541):39- ...
  7. Clinical Review Report Lanadelumab (Takhzyro) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK558612
    ... Takhzyro) (Shire Pharma Canada ULC) Indication: For routine prevention of attacks of hereditary angioedema in adolescents and adults CADTH Common Drug Review ...
  8. Berotralstat - LiverTox - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK605175
    ... et al. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase ... of ALT elevations or hepatotoxicity). Berotralstat (Orladeyo) for prevention of hereditary angioedema. Med Lett Drugs Ther. 2021;63(1629):e7- ...
  9. Pharmacoeconomic Review Report: Lanadelumab (Takhzyro) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK558382
    ... Shire Pharma Canada ULC) Indication: For the routine prevention of attacks of hereditary angioedema in adolescents and adults CADTH Common Drug Review ...
  10. Clinical Review - Berotralstat (Orladeyo) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK596626
    ... et al. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase ... al. Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial. JAMA . 2018;320( ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last